Minnesota legislation · 94th Legislature 2025-2026
Minnesota SF3971: Psilocybin therapeutic use program establishment
Status: In committee, April 20, 2026
What the bill says
A bill for an act relating to health; establishing a psilocybin therapeutic use program; establishing protections for registered patients, designated cultivators, registered facilitators, and health care practitioners; authorizing rulemaking; authorizing civil actions; establishing fees; classifying data; establishing an advisory committee; providing criminal penalties; appropriating money; proposing coding for new law in Minnesota Statutes, chapter 152.
From the introduced text, February 25, 2026:
A bill for an act relating to health; establishing a psilocybin therapeutic use program; establishing protections for registered patients, designated cultivators, registered facilitators, and health care practitioners; authorizing rulemaking; authorizing civil actions; establishing fees; classifying data; establishing an advisory committee; providing criminal penalties; appropriating money; proposing coding for new law in Minnesota Statutes, chapter 152. Section 1. new text begin [ADDED: PURPOSE.] new text end new text begin [ADDED: The purpose of this act is to establish a legal, regulated framework for the therapeutic use of psilocybin by individuals who are 21 years of age or older, have been diagnosed with a qualifying medical condition, and meet the other requirements for enrollment in the program. This act draws on the successes and lessons of Minnesota's medical cannabis program and emphasizes compassionate access, harm reduction, and patient safety.] new text end Sec. 2. new text begin [ADDED: [152.40] DEFINITIONS.] new text end new text begin [ADDED: Subdivision 1.] new text end new text begin [ADDED: Application.] new text end new text begin [ADDED: For the purposes of sections 152.40 to 152.53, the following terms have the meanings given.] new text end new text begin [ADDED: Subd. 2.] new text end new text begin [ADDED: Administration session.] new text end new text begin [ADDED: "Administration session" means a session supervised by a …
Sponsors
- Clare Oumou Verbeten (D) · primary sponsor
- Mark Koran (R)
- Liz Boldon (D)
- Lindsey Port (D)
- Judy Seeberger (D)
Latest actions
- : Author added Seeberger
- : Author added Port
- : Author added Boldon
- : Referred to Health and Human Services
- : Introduction and first reading
Common questions
- What is SF3971?
- SF3971 is a bill in the Minnesota Legislature (94th Legislature 2025-2026): Psilocybin therapeutic use program establishment.
- What does SF3971 do?
- In its own words: A bill for an act relating to health; establishing a psilocybin therapeutic use program; establishing protections for registered patients, designated cultivators, registered facilitators, and health care practitioners; authorizing rulemaking; authorizing civil actions; establishing fees; classifying data; establishing an advisory committee; providing criminal penalties; appropriating money; proposing coding for new law in Minnesota Statutes, chapter 152.
- What is the status of SF3971?
- In committee as of April 20, 2026. Latest action: Author added Seeberger (April 20, 2026).
- Who sponsored SF3971?
- Clare Oumou Verbeten (D), with 4 co-sponsors.
- Where is the official record for SF3971?
- On the Minnesota Legislature website: https://www.revisor.mn.gov/bills/bill.php?f=SF3971&y=2025&ssn=0&b=senate
Source: official Minnesota record. Tracked by Delilah, AI for legislation across all 50 states and Congress.